Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

TELA

TELA Bio Inc

Last Close
May 17 • 01:15PM ET
6.41
Dollar change
+0.05
Percentage change
0.71 		%
Held by: VTI IWM VXF IWO VTWO IWC JFWD VTWG RYLD GSSC Scroll to Statements
IndexRUT P/E- EPS (ttm)-1.67 Insider Own1.84% Shs Outstand24.49M Perf Week11.01%
Market Cap157.95M Forward P/E- EPS next Y-1.16 Insider Trans262.76% Shs Float24.20M Perf Month24.37%
Income-40.30M PEG- EPS next Q-0.46 Inst Own58.98% Short Float4.65% Perf Quarter-12.02%
Sales63.15M P/S2.50 EPS this Y25.15% Inst Trans17.15% Short Ratio6.93 Perf Half Y33.44%
Book/sh0.58 P/B10.98 EPS next Y24.14% ROA-61.70% Short Interest1.13M Perf Year-33.70%
Cash/sh1.51 P/C4.25 EPS next 5Y- ROE-459.89% 52W Range4.23 - 11.26 Perf YTD-3.25%
Dividend Est.- P/FCF- EPS past 5Y5.17% ROI-73.20% 52W High-43.12% Beta1.09
Dividend TTM- Quick Ratio3.23 Sales past 5Y49.61% Gross Margin68.97% 52W Low51.24% ATR (14)0.33
Dividend Ex-Date- Current Ratio4.13 EPS Y/Y TTM37.33% Oper. Margin-71.62% RSI (14)75.55 Volatility7.29% 5.64%
Employees227 Debt/Eq2.87 Sales Y/Y TTM40.03% Profit Margin-63.82% Recom1.00 Target Price14.20
Option/ShortYes / Yes LT Debt/Eq2.83 EPS Q/Q63.26% Payout- Rel Volume0.44 Prev Close6.36
Sales Surprise1.74% EPS Surprise52.95% Sales Q/Q39.42% EarningsMay 09 AMC Avg Volume162.48K Price6.41
SMA2029.31% SMA5023.67% SMA200-2.36% Trades Volume42,507 Change0.71%
Date Action Analyst Rating Change Price Target Change
May-31-22Initiated Lake Street Buy $17
Dec-03-19Initiated Piper Jaffray Overweight
Dec-03-19Initiated JMP Securities Mkt Outperform
Dec-03-19Initiated Jefferies Buy
Dec-03-19Initiated Canaccord Genuity Buy
May-13-24 11:01AM
TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript
(Insider Monkey)
May-10-24 04:05PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) +16.80%
03:51PM
TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth
(GuruFocus.com)
10:15AM
Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating
(MT Newswires)
May-09-24 04:05PM
TELA Bio Reports First Quarter 2024 Financial Results
(GlobeNewswire)
04:10PM Loading…
May-02-24 04:10PM
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript
(Insider Monkey)
Apr-25-24 07:00AM
TELA Bio to Announce First Quarter 2024 Financial Results
(GlobeNewswire)
Apr-15-24 07:00AM
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR - Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
(GlobeNewswire)
Apr-08-24 07:00AM
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
(GlobeNewswire)
Mar-22-24 09:46AM
TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript
(Insider Monkey) +7.10%
07:07AM
Q4 2023 TELA Bio Inc Earnings Call
(Thomson Reuters StreetEvents)
Mar-21-24 08:53PM
TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023
(InvestorPlace)
05:32PM
TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023
(GuruFocus.com)
05:30PM
TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates
(Zacks)
04:05PM
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
(GlobeNewswire)
07:00AM Loading…
07:00AM
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
(GlobeNewswire)
Mar-20-24 07:00AM
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
(GlobeNewswire)
07:00AM
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
(GlobeNewswire)
Feb-29-24 07:00AM
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
(GlobeNewswire)
Feb-23-24 04:05PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jan-19-24 04:05PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Dec-15-23 04:05PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Dec-05-23 07:00AM
TELA Bio to Take Part in Connecting the Dots
(GlobeNewswire) -6.68%
Nov-16-23 07:00AM
TELA Bio to Participate in Piper Sandler's 35th Annual Healthcare Conference
(GlobeNewswire)
Nov-12-23 12:20PM
TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript
(Insider Monkey)
Nov-10-23 04:05PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) -19.37%
Nov-09-23 04:05PM
TELA Bio Reports Third Quarter 2023 Financial Results
(GlobeNewswire)
Oct-26-23 07:00AM
TELA Bio to Announce Third Quarter 2023 Financial Results
(GlobeNewswire)
Sep-18-23 04:05PM
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
(GlobeNewswire)
Aug-16-23 07:00AM
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
(GlobeNewswire)
10:03AM Loading…
Aug-11-23 10:03AM
TELA Bio, Inc. (NASDAQ:TELA) Q2 2023 Earnings Call Transcript
(Insider Monkey)
Aug-10-23 09:18AM
Q2 2023 TELA Bio Inc Earnings Call
(Thomson Reuters StreetEvents)
Aug-09-23 06:05PM
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
(Zacks)
04:03PM
TELA Bio Reports Second Quarter 2023 Financial Results
(GlobeNewswire)
Aug-04-23 04:02PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jul-26-23 07:00AM
TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference
(GlobeNewswire)
Jul-06-23 10:09AM
Roivant Sciences Ltd. (ROIV) Surges 8.9%: Is This an Indication of Further Gains?
(Zacks)
Jun-18-23 07:51PM
Strength Seen in TELA Bio, Inc. (TELA): Can Its 11.4% Jump Turn into More Strength?
(Zacks)
Jun-15-23 07:00AM
New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options
(GlobeNewswire) -7.05%
May-25-23 07:00AM
TELA Bio to Participate in the Jefferies Global Healthcare Conference
(GlobeNewswire)
May-21-23 10:30AM
What You Can Learn From TELA Bio, Inc.'s (NASDAQ:TELA) P/S
(Simply Wall St.)
May-19-23 07:00AM
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
(GlobeNewswire)
May-12-23 07:44AM
Q1 2023 TELA Bio Inc Earnings Call
(Thomson Reuters StreetEvents)
May-11-23 05:25PM
TELA Bio, Inc. (TELA) Reports Q1 Loss, Misses Revenue Estimates
(Zacks)
04:02PM
TELA Bio Reports First Quarter 2023 Financial Results
(GlobeNewswire)
May-09-23 07:00AM
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
(GlobeNewswire)
May-08-23 04:30PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
May-02-23 07:00AM
TELA Bio to Participate in the JMP Securities Life Sciences Conference
(GlobeNewswire)
Apr-30-23 08:26AM
TELA Bio, Inc. (NASDAQ:TELA) stock most popular amongst private equity firms who own 36%, while individual investors hold 26%
(Simply Wall St.)
Apr-28-23 06:47PM
Dlocal, Augmedix See Activist Investor Action
(Barrons.com)
06:47PM
Dlocal and Augmedix Stock See Action From Activist Investors
(Barrons.com)
Apr-27-23 07:00AM
TELA Bio to Announce First Quarter 2023 Financial Results
(GlobeNewswire)
Apr-18-23 11:00PM
TELA Bio Announces Pricing of Public Offering of Common Stock
(GlobeNewswire)
04:01PM
TELA Bio Announces Proposed Public Offering of Common Stock
(GlobeNewswire)
Apr-03-23 06:14AM
TELA Bio's (NASDAQ:TELA) investors will be pleased with their notable 34% return over the last three years
(Simply Wall St.)
Mar-29-23 07:00AM
TELA Bios OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
(GlobeNewswire)
Mar-24-23 07:15AM
TELA Bio, Inc. (NASDAQ:TELA) Q4 2022 Earnings Call Transcript
(Insider Monkey)
Mar-23-23 07:00AM
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
(GlobeNewswire)
Mar-22-23 06:01AM
Q4 2022 TELA Bio Inc Earnings Call
(Thomson Reuters StreetEvents) -5.91%
Mar-21-23 05:15PM
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates
(Zacks)
04:02PM
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
(GlobeNewswire)
Mar-16-23 07:00AM
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
(GlobeNewswire) +5.74%
Feb-28-23 07:00AM
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
(GlobeNewswire)
Feb-24-23 04:02PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire) +5.05%
Feb-21-23 07:00AM
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
(GlobeNewswire)
Feb-14-23 07:00AM
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
(GlobeNewswire)
Jan-20-23 04:05PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jan-09-23 07:00AM
TELA Bio Announces U.S. Commercial Launch of NIVIS Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
(GlobeNewswire)
Dec-23-22 05:46AM
One TELA Bio, Inc. (NASDAQ:TELA) insider upped their stake by 342% in the previous year
(Simply Wall St.)
Dec-21-22 07:00AM
TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Dec-09-22 04:02PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Nov-21-22 07:00AM
TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
(GlobeNewswire)
Nov-12-22 07:42AM
TELA Bio Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
(Simply Wall St.)
Nov-09-22 05:25PM
TELA Bio, Inc. (TELA) Reports Q3 Loss, Tops Revenue Estimates
(Zacks) -8.71%
04:01PM
TELA Bio Reports Third Quarter 2022 Financial Results
(GlobeNewswire)
Nov-03-22 07:00AM
TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum
(GlobeNewswire) -7.19%
Oct-28-22 04:05PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Oct-27-22 07:00AM
TELA Bio to Announce Third Quarter 2022 Financial Results
(GlobeNewswire)
Oct-26-22 07:00AM
TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair
(GlobeNewswire)
Oct-24-22 10:24AM
The past year for TELA Bio (NASDAQ:TELA) investors has not been profitable
(Simply Wall St.)
Sep-01-22 07:00AM
TELA Bio to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Aug-23-22 04:01PM
TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase
(GlobeNewswire)
Aug-19-22 10:52AM
Lab Notes: Larimar readying response to the FDA's clinical hold; Tela Bio completes $36.8M stock sale
(American City Business Journals)
Aug-18-22 04:01PM
TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
(GlobeNewswire)
Aug-16-22 12:01PM
Tela Bio prices $32M public stock offering; share price drops
(American City Business Journals) -11.15%
Aug-15-22 10:20PM
TELA Bio Announces Pricing of Public Offering of Common Stock
(GlobeNewswire)
04:01PM
TELA Bio Announces Proposed Public Offering of Common Stock
(GlobeNewswire)
Aug-10-22 10:30PM
TELA Bio, Inc. (TELA) Q2 2022 Earnings Call Transcript
(Motley Fool)
05:35PM
TELA Bio, Inc. (TELA) Reports Q2 Loss, Tops Revenue Estimates
(Zacks)
04:01PM
TELA Bio Reports Second Quarter 2022 Financial Results
(GlobeNewswire)
Aug-05-22 07:00AM
TELA Bio to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Aug-04-22 07:00AM
TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting
(GlobeNewswire)
Jul-29-22 04:01PM
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
(GlobeNewswire)
Jul-27-22 07:00AM
TELA Bio to Announce Second Quarter 2022 Financial Results
(GlobeNewswire)
Jul-20-22 07:00AM
TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.
(GlobeNewswire)
Jul-08-22 06:45AM
Is TELA Bio, Inc. (NASDAQ:TELA) Popular Amongst Institutions?
(Simply Wall St.)
Jun-24-22 08:52AM
uniQure (QURE) Moves 27% Higher: Will This Strength Last?
(Zacks)
Jun-23-22 11:02AM
TELA Bio, Inc. (TELA) Stock Jumps 6.6%: Will It Continue to Soar?
(Zacks) +7.08%
Jun-10-22 06:15AM
Trade Alert: The CFO & COO Of TELA Bio, Inc. (NASDAQ:TELA), Roberto Cuca, Has Just Spent US$83k Buying 342% More Shares
(Simply Wall St.) -8.15%
Jun-02-22 07:00AM
TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference
(GlobeNewswire)
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Firestone Gregory A.Chief Business OfficerDec 05 '23Buy5.652,60014,68835,511Dec 07 04:02 PM
KOBLISH ANTONYChief Executive OfficerNov 14 '23Buy4.5411,00049,976303,634Nov 14 08:01 PM
Cuca RobertoCOO and CFONov 14 '23Buy4.4910,00044,93862,371Nov 14 08:02 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.